| J2350 | Injection, ocrelizumab, 1 mg | 7 | 10 | 310 | $20,560 | $10M |
| J2323 | Injection, natalizumab, 1 mg | 1 | 10 | 440 | $4,300 | $3.2M |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,794 | 4,510 | 500 | $60 | $377.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 22 | 100 | 1,000 | $120 | $357.1K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 3,566 | 5,080 | 560 | $40 | $323.9K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 28 | 40 | 700 | $280 | $287.1K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 172 | 190 | 5,470 | $1 | $28.2K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 79 | 150 | 380 | $1 | $620 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 119 | 120 | 220 | $1 | $140 |